Journal for ImmunoTherapy of Cancer (Nov 2023)
398 Utilizing a Th17 polarization strategy for generating high quality human TIL products for patients with advanced solid tumors
Abstract
No abstracts available.
Journal for ImmunoTherapy of Cancer (Nov 2023)